在老年人中重新思考抗胆固醇负担:检测和管理的创新方法
Geofrey Oteng Phutietsile1, Prasad S Nishtala1,2
1Department of Life Sciences, University of Bath, Bath, UK.
抗胆固醇负担 (AChB) 评估工具正在发展. 较新的AI和数字健康方法有望提高准确性和整合性,以改善老年人药物管理.
科学领域:
- 老年学是一门学科.
- 临床药房 临床药房
- 医疗信息学 医疗信息学
背景情况:
- 抗胆固醇负担 (AChB) 是老年人不良结果的重要风险因素,包括认知能力下降和跌倒.
- 现有的ACHB评估工具缺乏共识的黄金标准,并且经常使用静态药物排名,限制了它们的适应性.
研究的目的:
- 审查最近在测量AChB和促进药物减缓处方方面的进展.
- 批判性地评估传统的 AChB 工具和新兴的 AI 驱动模型.
- 探索数字健康在风险分层和干预中的作用.
主要方法:
- 关于ACHB测量和减记的文献叙述性综述.
- 评估已建立的工具 (ACB尺度,DBI) 和新型机器学习模型 (ML-AB尺度).
- 探索数字健康创新 (临床决策支持,可穿戴设备).
主要成果:
- 传统的ACHB工具在适应性和工作流集成方面存在局限性.
- 人工智能和数据驱动的方法提供了更好的预测准确性和可扩展性.
- 数字健康工具可以改善风险分层和降低干预措施.
结论:
- 对于ACHB管理,正在出现一种将机械学和实证方法结合在一起的混合系统的范式转变.
- 未来的抑郁症描述工作需要验证,以患者为中心的工具,在不同的环境中实施.
- 整合人工智能和数字健康创新对于优化 AChB 评估和干预至关重要.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
相关概念视频
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Alzheimer's Disease: Treatment
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
